Cathay Biotech Inc.
688065.SSFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
414
Cost of Revenue
297
Gross Profit
117
Gross Margin
28.3%
Operating Income
77
Operating Margin
18.6%
Net Income
68
Net Margin
16.5%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
95
EBITDA Margin
23.0%
2023
12/31/2023
Revenue
296
Cost of Revenue
215
Gross Profit
81
Gross Margin
27.4%
Operating Income
64
Operating Margin
21.5%
Net Income
51
Net Margin
17.3%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
63
EBITDA Margin
21.3%
2022
12/31/2022
Revenue
342
Cost of Revenue
226
Gross Profit
116
Gross Margin
34.0%
Operating Income
99
Operating Margin
29.0%
Net Income
77
Net Margin
22.7%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
94
EBITDA Margin
27.5%
2021
12/31/2021
Revenue
331
Cost of Revenue
214
Gross Profit
117
Gross Margin
35.4%
Operating Income
101
Operating Margin
30.6%
Net Income
83
Net Margin
25.2%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
93
EBITDA Margin
28.3%
2020
12/31/2020
Revenue
210
Cost of Revenue
113
Gross Profit
96
Gross Margin
46.0%
Operating Income
73
Operating Margin
34.9%
Net Income
64
Net Margin
30.6%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
79
EBITDA Margin
37.8%